Viewing nowCombinationEmpagrom 5/1000 mg (Empagliflozin, Metformin Hydrochloride)
Empagliflozin 5mg · Metformin Hydrochloride 1000mg
Tablet · Prescription medication · Combination
Hanlim Pharmaceutical Co., Ltd.

MFDS item code 202501690 · Approved 2025.07.08 · Insurance code 645307220
Improvement of glycemic control in adults with type 2 diabetes mellitus
This medication is used to assist in controlling blood sugar levels in adult patients with type 2 diabetes by combining Empagliflozin and Metformin. It is suitable for patients who follow dietary and exercise therapies, especially those whose blood sugar is not adequately controlled. It is also used cautiously in type 2 diabetes patients with cardiovascular disease. This medication improves blood sugar control and helps in diabetes management.
The recommended dose of this medicine is 1 tablet twice daily. The dose should be determined based on each patient's current treatment regimen, efficacy, and tolerability, without exceeding the maximum recommended daily doses of each component: empagliflozin 25 mg and metformin 2000 mg. ⦁ For patients who are unable to achieve adequate glycemic control with metformin alone or in combination with other medicines such as insulin, the recommended dose is empagliflozin 5 mg twice daily (total daily dose 10 mg) and the patient's current metformin dose. If empagliflozin 10 mg (total daily dose) is well tolerated and additional glycemic control is needed, the dose may be increased to empagliflozin 25 mg (total daily dose). ⦁ Patients switching to this medicine from combination therapy with empagliflozin (total daily dose 10 mg or 25 mg) and metformin should receive their previous doses of empagliflozin and metformin. When this medicine is used concomitantly with a sulfonylurea or insulin, a reduction in the dose of the sulfonylurea or insulin may be considered to reduce the risk of hypoglycemia (see Precautions for Use 4. Adverse Reactions and 6. Interactions). This medicine should be taken with meals to reduce gastrointestinal adverse reactions associated with metformin. If you miss a dose, take it as soon as you remember. However, do not take a double dose at one time; in this case, skip the missed dose. Special populations Patients with renal impairment No dose adjustment is required in patients with mild renal impairment. Because this medicine contains metformin, it may be used with dose adjustment in patients with an estimated glomerular filtration rate (eGFR) of 45-59 ml/min/1.73m2 or a CrCl of 45-59 ml/min who do not have other conditions that may increase the risk of lactic acidosis. In these patients, the starting dose of metformin is 500 mg or 850 mg once daily; therefore, treatment should be initiated with the individual components, empagliflozin and metformin. The maximum daily dose of metformin hydrochloride that may be administered with this medicine is 1000 mg, given as 500 mg twice daily. Renal function should be carefully monitored every 3-6 months (see Precautions for Use 3. Patients Requiring Caution, item 1)). If renal function declines to CrCl <45 ml/min or eGFR <45 ml/min/1.73m2, this medicine should be discontinued immediately (see Precautions for Use 2. Patients in Whom the Medicine Must Not Be Used, item 2)). Elderly patients Renal function and the risk of volume depletion should be considered in patients aged 75 years or older.
This medication is used to control blood sugar as a diabetes treatment. While taking this medication, special attention should be paid due to the risk of a rare side effect called lactic acidosis. Lactic acidosis is a dangerous condition caused by the excessive accumulation of lactate in the body, which can sometimes be life-threatening. Additionally, caution is advised when taking this medication alongside insulin or sulfonylureas, as it may increase the risk of hypoglycemia, meaning that blood sugar could drop too low. This medication should not be used in patients with severely impaired renal function or in conditions such as acute infection, dehydration, heart failure, or acute myocardial infarction. If iodine contrast agents are used for examinations, this medication should be discontinued for a certain period before and after the examination and resumed only after confirming that kidney function is normal. Women who are pregnant or breastfeeding are advised not to take this medication. This medication can cause fluid loss, so it is important to be cautious about dehydration or low blood pressure, especially in elderly patients or those with cardiovascular disease. While on this medication, the risk of urinary tract infections or genital infections may increase, so if any signs of infection appear, contact medical personnel immediately. The Metformin component may lower vitamin B12 levels, so if taken long-term, it is advisable to regularly check vitamin B12 levels. Furthermore, it is important to avoid excessive alcohol consumption while on this medication, and if symptoms of hypoglycemia, lactic acidosis, or ketoacidosis appear, immediate medical attention should be sought. If preparing for surgery or unable to eat properly due to an acute illness, this medication should be temporarily stopped, and consultation with a doctor is necessary. This medication is not recommended for children, and elderly patients need appropriate dose adjustment with kidney function monitoring. In case of overdose, immediate medical attention is required, and blood dialysis may be necessary. Keep this medication out of reach of children and store it in its original container for safety.
Not everyone experiences these, and they can vary from person to person.
Store this medication in a tightly sealed container to protect it from air and moisture. The storage temperature should be maintained between 1 and 30 degrees Celsius at room temperature.
Brownish-yellow, bilaterally convex, oval-shaped film-coated tablet
60 tablets/bottle, 60 tablets/box [10 tablets/PTP x 6]
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowCombinationEmpagliflozin 5mg · Metformin Hydrochloride 1000mg
Tablet · Prescription medication · Combination
Hanlim Pharmaceutical Co., Ltd.
CombinationEmpagliflozin 5mg · Metformin Hydrochloride 500mg
Tablet · Prescription medication · Combination
Boehringer Ingelheim Korea Co., Ltd.
CombinationEmpagliflozin 5mg · Metformin Hydrochloride 850mg
Tablet · Prescription medication · Combination
Boehringer Ingelheim Korea Co., Ltd.
CombinationEmpagliflozin 5mg · Metformin Hydrochloride 1000mg
Tablet · Prescription medication · Combination
Boehringer Ingelheim Korea Co., Ltd.
CombinationEmpagliflozin 12.5mg · Metformin Hydrochloride 500mg
Tablet · Prescription medication · Combination
Boehringer Ingelheim Korea Co., Ltd.
CombinationEmpagliflozin 12.5mg · Metformin Hydrochloride 850mg
Tablet · Prescription medication · Combination
Boehringer Ingelheim Korea Co., Ltd.
CombinationEmpagliflozin 12.5mg · Metformin Hydrochloride 1000mg
Tablet · Prescription medication · Combination
Boehringer Ingelheim Korea Co., Ltd.
CombinationEmpagliflozin 5mg · Metformin Hydrochloride 500mg
Tablet · Prescription medication · Combination
Donggu Bio Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.